申请人:BASF Aktiengesellschaft
公开号:US04921861A1
公开(公告)日:1990-05-01
The 3-amino-4-ethylthio-quinoline of the Formula I ##STR1## and pharmaceutically acceptable acid addition salts thereof possess useful therapeutical properties. They exhibit a potent and highly selective anxiolytic and narcosis potentiating effect and are devoid of sedative and anti-convulsive effect. Consequently, the invention relates to pharmaceutical compositions comprising the compound of Formula I or a salt thereof as active agent. The invention also relates to a new and improved process for the preparation of the compound of Formula I.
公式I中的3-氨基-4-乙硫基-喹啉及其药学上可接受的酸盐具有有用的治疗性质。它们表现出强效和高度选择性的抗焦虑和麻醉增强效果,并且不具有镇静和抗惊厥效果。因此,本发明涉及包含公式I化合物或其盐作为活性剂的药物组合物。本发明还涉及一种新的和改进的制备公式I化合物的方法。